Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study

References

• Sharma P, Sample PA, Zangwill LM, Suhuman JS. Diagnostic tools for glaucoma detection and management. Surv Ophthalmol 2008;53:17–32
   PubMed Web of Science ®Google Scholar
• Kaur IP, Smitha R, Aggarwal D, Kapil, M. Aceatzolamide: future perspective in topical glaucoma therapeutics. Int J Pharm 2002;248:1–14
   PubMed Web of Science ®Google Scholar
• Kaur IP, Kapil M, Smitha R, Aggarwal D. Development of topically effective formulations of acetazolamide using HP-β-CD polymer co-complexes. Curr Drug Deliv 2004;1:65–72
   PubMedGoogle Scholar
• El-Gazayerly ON, Hikal AH. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm 1997;158:121–7
   Web of Science ®Google Scholar
• Aggarwal D, Pal D, Mitra AK, Kaur IP. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int J Pharm 2007;338:21–6
   PubMed Web of Science ®Google Scholar
• Durate ARC, Roy C, Gonzalez AV, et al. Preparation of acetazolamide composite microparticle by supercritical anti-solvent techniques. Int J Pharm 2007;332:132–9
   PubMed Web of Science ®Google Scholar
• Friedman Z, Allen CR, Raph MS. Topical acetazolamide and methazolamide delivery by contact lenses. Arch Opthalmol 1985;103:963–6
   PubMed Web of Science ®Google Scholar
• Sasaki H, Yamamura K, Mukai T, et al. Enhancement of ocular drug penetration. Crit Rev Ther Drug Carr Syst 1999;16:85–146
   PubMed Web of Science ®Google Scholar
• Gan L, Gan Y, Zhu C, et al. Novel microemulsion in-situ electrolyte- triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results. Int J Pharm 2009;365:143–9
   PubMed Web of Science ®Google Scholar
• Das S, Suresh PK. Drug delivery to eye: special reference to nanoparticles. Int J Drug Deliv 2010;2:12–21
   Google Scholar
• Dillen K, Vandervoort J, Mooter GVD, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm 2006;314:72–82
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav CS. Biodegradable polymeric nanoparticles based drug delivery system. Colloids Surf B 2010;75:1–18
   PubMed Web of Science ®Google Scholar
• Nagarwal CR, Kant S, Singh PN, et al. Polymeric nanoparticulate system: a potential approach for ocular delivery. J Control Rel 2009;136:2–13
   PubMed Web of Science ®Google Scholar
• Araujo J, Vega E, Lopes C, et al. Effect of polymer on physiochemical properties and ocular tolerance of FB-loaded PLGA nanosphere. Colloids Surf B 2009;72:48–56
   PubMed Web of Science ®Google Scholar
• Soppimath SK, Aminabhavi MT, Kulkarni RA, Rudzinski EW. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Rel 2001;70:1–20
   PubMed Web of Science ®Google Scholar
• Nanjawade BK, Manvi FV, Manjappa AS. In-situ forming hydrogels for sustained ophthalmic drug delivery. J Control Rel 2007;122:119–34
   PubMed Web of Science ®Google Scholar
• Vodithala S, Khatry S, Shastri N, Sadanandam M. Formulation and evaluation of ion activated ocular gels of ketorolac tromethamine. Int J Current Pharm Res 2010;2:33–8
   Google Scholar
• Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm 2010;36:1330–9
   PubMed Web of Science ®Google Scholar
• Agrawal AK, Das M, Jain S. In situ gel systems as “smart” carriers for sustained ocular drug delivery. Exp Opi Drug Del 2012;9:383–402
   PubMed Web of Science ®Google Scholar
• Lin RH, Sung CK. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Rel 2000;69:379–88
   PubMed Web of Science ®Google Scholar
• Qi H, Chen W, Huang C, et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 2007;337:178–87
   PubMed Web of Science ®Google Scholar
• Gupta H, Aquil M, Khar RK, et al. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular delivery. Nanomedicine Nat Nanotechnol 2010;6:324–33
   PubMed Web of Science ®Google Scholar
• Pathak MK, Chhabra G, Pathak K. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Dev Ind Pharm 2013;39:780–90
   PubMed Web of Science ®Google Scholar
• Lin RH, Sung CK. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Rel 2000;69:379–88
   PubMed Web of Science ®Google Scholar
• Suryawanshi SS, Kunjwani HK, Kawade JV, et al. Novel polymeric in-situ gels for ophthalmic drug delivery system. Int J Pharm Sci 2012;2:67–83
   Google Scholar
• Doijad RC, Manvi FV, Rao Malleswara VSN, Alase P. Sustained ophthalmic delivery of gatifloxacin from in-situ gelling system. Int J Pharm Sci 2006;68:814–18
   Google Scholar
• Wilhelmus KR. The Draize eye test. Surv Ophthalmol 2001;46:493–515
   Web of Science ®Google Scholar
• Lallemand F, Furrer P, Baeyens OF, et al. A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics. Int J Pharm 2005;295:7–14
   PubMed Web of Science ®Google Scholar
• Zimmer A, Kreuter J. Microsphere and nanoparticles used in ocular delivery systems. Adv Drug Del Rev 1995;16:61–73
   Web of Science ®Google Scholar
• Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in-vitro and in-vivo studies. Acta Biomater 2011;7:4169–76
   PubMed Web of Science ®Google Scholar
• Das S, Suresh Pk. Drug delivery to eye: special reference to nanoparticles. Int J Drug Deliv 2010;2:12–21
   Google Scholar
• Agnihotri SM, Vavia PR. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic applications. Nanomedicine Nat Nanotechnol 2009;5:90–5
   PubMed Web of Science ®Google Scholar
• Chhabra G, Chuttani K, Mishra AK, Pathak K. Design and evaluation of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev Ind Pharm 2011;37:907–16
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Ferrara P, et al. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 2002;16:53–61
   PubMed Web of Science ®Google Scholar
• Yilmaz ST, Maden A. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endopphthalmitis. Cornea 2007;26:398–402
   PubMed Web of Science ®Google Scholar
• Wu H, Liu Z, Peng J, et al. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery. Int J Pharm 2011;410:31–40
   PubMed Web of Science ®Google Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm 1999;25:471–6
   PubMed Web of Science ®Google Scholar
• Leung L, Chan C, Baek S, Naguib H. Comparison of morphology and mechanical properties of PLGA bioscaffolds. Biomed Mater 2008;3:025006
   Google Scholar
• Jeong B, Kim SW, Bae YH. Thermosenstive sol--gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37–51
   PubMed Web of Science ®Google Scholar
• Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)- based drug delivery systems – a review. Int J Pharm 2011;415:34–52
   PubMed Web of Science ®Google Scholar
• Aksungur P, Demirbilek M, Denkbas EB, et al. Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetics studies. J Control Rel 2011;151:286–94
   PubMed Web of Science ®Google Scholar
• Srividya B, Cardoza RM. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Rel 2001;73:205–11
   PubMed Web of Science ®Google Scholar
• Soppimath SK, Aminabhavi MT, Kulkarni RA, Rudzinski EW. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Rel 2001;70:1–20
   PubMed Web of Science ®Google Scholar
• Wu H, Liu Z, Peng J, et al. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery. Int J Pharm Sci 2011;410:31–40
   PubMed Web of Science ®Google Scholar
• Iglesias RB, Lorenzo A, Concheiro A. Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of Carbopol gels. Int J Control Rel 2001;77:59–75
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav CS. Biodegradable polymeric nanoparticles based drug delivery system. Colloids Surf B 2010;75:1–18
   PubMed Web of Science ®Google Scholar
• Sharma R, Ahuja M, Kaur H. Thiolated pectin nanoparticles: preparation, characterization and ex-vivo corneal permeation study. Carbohydrates Polymers 2012;87:1606–10
   Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Dis Today 2008;13:144–51
   PubMed Web of Science ®Google Scholar